KALA BIO, INC. Operating Cash Flow
KALA BIO, INC. (KALA) reported Operating Cash Flow of -$4.43 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-19
- KALA BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.53M.
- KALA BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.90M.
- KALA BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$4.56M.
- KALA BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$10.88M.
- KALA BIO, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$31.99M.
- KALA BIO, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$29.38M.
- KALA BIO, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$27.93M.
- KALA BIO, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$78.91M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | -$4.43M 10-Q · filed 2026-08-19 | -$8.99M derived: sum of 3 quarters · filed 2026-08-19 | -$19.86M derived: sum of 4 quarters · filed 2026-08-19 | ||
| 2026-03-31 | -$2.90M 10-Q · filed 2026-05-15 | -$7.45M derived: sum of 2 quarters · filed 2026-05-15 | -$18.33M derived: sum of 3 quarters · filed 2026-05-15 | -$34.89M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-12-31 | -$4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$15.43M derived: sum of 2 quarters · filed 2026-04-15 | -$31.99M derived: sum of 3 quarters · filed 2026-04-15 | -$31.99M 10-K · filed 2026-04-15 | ||
| 2025-09-30 | -$10.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$27.43M derived: sum of 2 quarters · filed 2025-11-19 | -$27.43M 10-Q · filed 2025-11-19 | -$40.86M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-06-30 | -$16.56M 10-Q · filed 2025-08-08 | -$16.56M 10-Q · filed 2026-08-19 | -$29.98M derived: sum of 3 quarters · filed 2026-05-15 | -$34.70M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-03-31 | -$8.82M 10-Q · filed 2026-05-15 | -$13.42M derived: sum of 2 quarters · filed 2026-05-15 | -$18.15M derived: sum of 3 quarters · filed 2026-05-15 | -$27.36M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$9.32M derived: sum of 2 quarters · filed 2026-04-15 | -$18.54M derived: sum of 3 quarters · filed 2026-04-15 | -$29.38M 10-K · filed 2026-04-15 | ||
| 2024-09-30 | -$4.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$13.94M derived: sum of 2 quarters · filed 2025-11-19 | -$24.78M 10-Q · filed 2025-11-19 | -$32.48M derived: sum of 4 quarters · filed 2025-11-19 | ||
| 2024-06-30 | -$9.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$20.06M 10-Q · filed 2025-08-08 | -$27.75M derived: sum of 3 quarters · filed 2025-08-08 | -$30.71M derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2024-03-31 | -$10.84M 10-Q · filed 2025-05-14 | -$18.54M derived: sum of 2 quarters · filed 2025-05-14 | -$21.49M derived: sum of 3 quarters · filed 2025-05-14 | -$29.09M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$10.65M derived: sum of 2 quarters · filed 2025-03-31 | -$18.24M derived: sum of 3 quarters · filed 2025-03-31 | -$27.93M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | -$2.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$10.55M derived: sum of 2 quarters · filed 2024-11-12 | -$20.23M 10-Q · filed 2024-11-12 | -$33.97M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$7.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$17.28M 10-Q · filed 2024-08-06 | -$31.01M derived: sum of 3 quarters · filed 2024-08-06 | -$46.68M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | -$9.68M 10-Q · filed 2024-05-14 | -$23.42M derived: sum of 2 quarters · filed 2024-05-14 | -$39.08M derived: sum of 3 quarters · filed 2024-05-14 | -$64.50M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | -$13.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$29.40M derived: sum of 2 quarters · filed 2024-03-29 | -$54.82M derived: sum of 3 quarters · filed 2024-03-29 | -$78.91M 10-K · filed 2024-03-29 | ||
| 2022-09-30 | -$15.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$41.08M derived: sum of 2 quarters · filed 2023-11-13 | -$65.17M 10-Q · filed 2023-11-13 | -$93.08M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$25.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$49.51M 10-Q · filed 2023-08-04 | -$77.41M derived: sum of 3 quarters · filed 2023-08-04 | -$103.50M derived: sum of 4 quarters · filed 2023-08-04 | ||
| 2022-03-31 | -$24.09M 10-Q · filed 2023-05-09 | -$51.99M derived: sum of 2 quarters · filed 2023-05-09 | -$78.08M derived: sum of 3 quarters · filed 2023-05-09 | -$99.68M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | -$27.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | -$53.99M derived: sum of 2 quarters · filed 2023-03-03 | -$75.59M derived: sum of 3 quarters · filed 2023-03-03 | -$108.23M 10-K · filed 2023-03-03 | ||
| 2021-09-30 | -$26.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$47.69M derived: sum of 2 quarters · filed 2022-11-08 | -$80.33M 10-Q · filed 2022-11-08 | -$106.25M derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | -$21.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$54.25M 10-Q · filed 2022-08-11 | -$80.17M derived: sum of 3 quarters · filed 2022-08-11 | -$105.81M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$32.64M 10-Q · filed 2022-05-16 | -$58.56M derived: sum of 2 quarters · filed 2022-05-16 | -$84.20M derived: sum of 3 quarters · filed 2022-05-16 | -$103.45M derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | -$25.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$51.56M derived: sum of 2 quarters · filed 2022-03-29 | -$70.81M derived: sum of 3 quarters · filed 2022-03-29 | -$90.69M 10-K · filed 2022-03-29 | ||
| 2020-09-30 | -$25.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$44.90M derived: sum of 2 quarters · filed 2021-11-15 | -$64.78M 10-Q · filed 2021-11-15 | -$82.99M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | -$19.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$39.13M 10-Q · filed 2021-08-05 | -$57.35M derived: sum of 3 quarters · filed 2021-08-05 | -$80.26M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | -$19.88M 10-Q · filed 2021-05-05 | -$38.09M derived: sum of 2 quarters · filed 2021-05-05 | -$61.00M derived: sum of 3 quarters · filed 2021-05-05 | -$81.43M derived: sum of 4 quarters · filed 2021-05-05 | ||
| 2019-12-31 | -$18.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$41.12M derived: sum of 2 quarters · filed 2021-02-25 | -$61.55M derived: sum of 3 quarters · filed 2021-02-25 | -$92.72M 10-K · filed 2021-02-25 | ||
| 2019-09-30 | -$22.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$43.34M derived: sum of 2 quarters · filed 2020-11-05 | -$74.51M 10-Q · filed 2020-11-05 | -$90.50M derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | -$20.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$51.60M 10-Q · filed 2020-08-06 | -$67.58M derived: sum of 3 quarters · filed 2020-08-06 | -$83.80M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | -$31.17M 10-Q · filed 2020-05-07 | -$47.16M derived: sum of 2 quarters · filed 2020-05-07 | -$63.37M derived: sum of 3 quarters · filed 2020-05-07 | -$72.58M derived: sum of 4 quarters · filed 2020-05-07 | ||
| 2018-12-31 | -$15.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | -$32.20M derived: sum of 2 quarters · filed 2020-02-12 | -$41.41M derived: sum of 3 quarters · filed 2020-02-12 | -$54.12M 10-K · filed 2020-02-12 | ||
| 2018-09-30 | -$16.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$25.42M derived: sum of 2 quarters · filed 2019-11-07 | -$38.13M 10-Q · filed 2019-11-07 | -$44.70M derived: sum of 4 quarters · filed 2019-11-07 | ||
| 2018-06-30 | -$9.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$21.92M 10-Q · filed 2019-08-06 | -$21.91M 10-Q · filed 2018-08-09 | -$28.48M derived: sum of 3 quarters · filed 2019-08-06 | -$37.81M derived: sum of 4 quarters · filed 2019-08-06 | |
| 2018-03-31 | -$12.71M 10-Q · filed 2019-05-09 | -$12.71M 10-Q · filed 2018-05-10 | -$19.28M derived: sum of 2 quarters · filed 2019-05-09 | -$28.61M derived: sum of 3 quarters · filed 2019-05-09 | -$37.45M derived: sum of 4 quarters · filed 2019-05-09 | |
| 2017-12-31 | -$6.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$15.89M derived: sum of 2 quarters · filed 2019-03-12 | -$24.74M derived: sum of 3 quarters · filed 2019-03-12 | -$34.10M 10-K · filed 2019-03-12 | ||
| 2017-09-30 | -$9.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$18.18M derived: sum of 2 quarters · filed 2018-11-08 | -$27.53M 10-Q · filed 2018-11-08 | -$34.86M derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2017-06-30 | -$8.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$18.20M 10-Q · filed 2018-08-09 | -$25.53M derived: sum of 3 quarters · filed 2018-08-09 | -$33.68M derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2017-03-31 | -$9.36M 10-Q · filed 2018-05-10 | -$16.68M derived: sum of 2 quarters · filed 2018-05-10 | -$24.83M derived: sum of 3 quarters · filed 2018-05-10 | |||
| 2016-12-31 | -$7.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$15.47M derived: sum of 2 quarters · filed 2018-04-02 | -$27.35M 10-K · filed 2018-04-02 | |||
| 2016-09-30 | -$8.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$20.02M 10-Q · filed 2017-11-07 | ||||
| 2016-06-30 | -$11.88M 10-Q · filed 2017-08-31 | |||||
| 2015-12-31 | -$15.09M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |